Welcome Letter from
MIXiii-Biomed 2019
Co-Chairpersons

The Full Spectrum of Healthcare: From Prevention to Rehabilitation and Everything in Between

Dear Friends and Colleagues,

It is our honor and pleasure to invite you to participate in the 18th MIXiii-BIOMED Conference and Exhibition, to be held May 14-16, 2019 in Tel Aviv, Israel.

INVITED SPEAKERS

Robert King, PhD
Partner at Goldman Sachs International and Global Vice Chairman, Investment Banking Division

Barry Greene
President, Alnylam Pharmaceuticals

Amy W. Schulman
Healthcare Investor and Managing Partner, LS Polaris Innovation Fund

Todd Brinton, MD
Corporate Vice President, Advanced Technology and Chief Scientific Officer, Edwards Lifesciences

Tom Sudow
Director, Business Development, Cleveland Clinic Innovations

Mark D. Stovsky, MD, MBA, FACS
Senior Director, Emerging Business, Cleveland Clinic Ventures

Francois Maisonrouge
Senior Managing Director, Evercore Partners

Fiona de Hemptinne
Venture Partner, UCB Ventures

Miriam Frieden
Novo Nordisk

Iskra Reic
Executive Vice President, Europe and Canada, AstraZeneca

Laurent Choppe, DVM
Managing Partner, Cukierman & Co. Life Sciences

Zafrira Avnur, PhD
CSO & Partner, VP Quark Venture USA

Aya Jakobovits, PhD
Founder, Director, Adicet Bio

Erez Chimovits
Senior Managing Director, OrbiMed Advisors

Anat Naschitz
Managing Director, OrbiMed Advisors

Irit Yaniv, MD
General Partner, Accelmed

Ron Ginor, MD
Venture Partner, OrbiMed Advisors

Naomi Gefen
Deputy Director General, ALYN Hospital

Prof. Yael Hanein, PhD
School of Electrical Engineering, Tel Aviv University

Yaron Daniely, PhD
CEO, Yissum

Yael Weiss, MD, PhD
Vice President Business Development, Ultragenyx

Stephen Squinto, PhD
Venture Partner, OrbiMed Advisors, L.L.C

Prof. David Sidransky, MD
Johns Hopkins School of Medicine; Co-Founder and General Partner, Israel Biotech Fund

Prof. Varda Shalev, MD, MPA
Managing Director, Morris Kahn & Maccabi Research and Innovation Institute at Maccabi Health Care Services

Yair Schindel, MD
Co-Founder & Managing Partner, aMoon Fund

Allen Kamer
Managing Partner, OurCrowd Qure

Prof. Simon Benita, PhD
Head of Nano Delivery Systems, Hebrew University of Jerusalem

Ayelet Torem, Adv.
Partner, Hi-Tech & Venture Capital and Head of Global Markets, Amit, Pollak, Matalon & Co

Dorman Followwill
Senior Partner, Frost & Sullivan

Prof. Nadav Ahituv, PhD
Department of Bioengineering and Therapeutic Science, UCSF

Rachel Haurwitz, PhD
Co-founder, President and CEO, Caribou Biosciences

Ulrich Brinkmann, PhD
Scientific Director, Roche Pharma Research & Early Development, Roche Diagnostics GmbH

Pavel Pisa, MD, PhD
Group Head, Global Early and Late Clinical Development, Roche

Michal J. Besser, PhD
Head of Laboratory, Ella Lemelbaum Institute for Immuno Oncology, Sheba Medical Center; Director, Wohl GMP Facility, Sheba Medical Center; Assistant Professor, Dept. of Microbiology and Immunology, School of Medicine, Tel Aviv University

Adi Barzel, PhD
Senior Lecturer, Department of Biochemistry at Tel Aviv University; Co-Founder of LogicBio Therapeutics, Inc.; President of the Israeli Society of Gene and Cell Therapy

Bruce R. Rosengard, MD
VP, Global External Innovation, Johnson and Johnson Medical Devices

John J. Smith, MD
Partner, Hogan Lovells

Kandeepan Ganeshalingam, MD
Executive Director Therapeutic Area Head Oncology – EU Clinical Development, Merck Sharpe & Dohme

Trevor Martin, PhD 
CEO and Co-Founder, Mammoth Biosciences

Elliot Menshick, MD
Global Head, Healthcare + Life Science Startups, Amazon Web Services

Kelly Krajnik
Senior Manager, Devices, Diagnostics, Mayo Clinic Ventures

Kimberly N. Hanke
Sr. Contract Manager, Legal Contract, Administration, Mayo Clinic

On the agenda

14 May 2019

Gene Editing and Gene Therapy: The Next Frontier in Human Health
Deep Diving: The Role of Artificial Intelligence and Digital Health in Medicine
Disruptive and Advanced Medical Devices

15 May 2019

Prevention and Rehabilitation: Should the Underdog Begin Barking?
Tango of the Two: Academia and Industry
New Modalities of Cell Therapies: Revolutionizing the Way We Treat Diseases

16 May 2019

Transformative Cancer Therapies
Personalized Medicine and Digital Health: Lessons Learned and Challenges Ahead
Cannabis’ Therapeutic Promise: Hope or Hype?

ORGANIZERS

Conferences-Exhibitions--Education
Hadassa-logo-transparent
Cleveland-Clinic-Innovations-transparent
Rambam-logo-transparent
Souraski-logo-transparent

IN COOPERATION WITH

DIAMOND SPONSOR

GOLD SPONSORS

Johnson-Johnson-innovation-transparent
Orbimed-logo-transparent
Ferring-logo-transparent
Latham&Watkins-logo-transparent
Covington-logo-transparent

SILVER SPONSORS

Medison-logo-transparent
MSD-logo-transparent
Pitango-logo-transparent
HCWainwright&Co-logo-transparent
Jefferies-logo-transparent

BRONZE SPONSOR

BRM-logo-transparent

MEDIA PARTNER

Be Informed, Stay Informed

Follow us on:

Join our group in LinkedIn:

Linkedin-groups-transparent

 

Read all news about the event and the field in our blog: